The Asheville Project “Asheville”.

Slides:



Advertisements
Similar presentations
Economic Impact of a Sedentary Lifestyle. Exercise and Body Composition The health care costs associated with obesity treatment were estimated at $117.
Advertisements

Better Health, Lower Health Costs: An Overview of the Asheville Model Right Care Initiative Scott Sproull, Vice President GlaxoSmithKline.
Disease State Management The Pharmacist’s Role
The Maryland P 3 Program: A Collaborative Solution to Medication Therapy Management Magaly Rodriguez de Bittner, PharmD, BCPS, FAPhA, CDE Professor and.
The Value of Medication Therapy Management Services.
Disease Management Diabetes Results: Represents Health Disparities Collaborative for Diabetes Overall CAP Results.
Healthy Purdue Stacey L. Mobley, PhD, RD, CNSD Assistant Professor Department of Foods and Nutrition A Platform for Research in Disease Prevention and.
STOPPING DIABETES STARTS NOW
Diabetes: The Numbers Michigan Diabetes Partners in Action and Michigan Department of Community Health Diabetes: The Numbers Adapted from the National.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Kidney Diseases Prevention. Overview The mortality rate of Nephritis, Nephrotic Syndrome, and Nephrosis (18.15 per 100,000 population) marching the 7th.
APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Diabetes and PVD.
National Diabetes Education Program NDEP ( ) A joint program of NIH and CDC Diabetes: The Numbers Revised.
Engaging Consumers to Purchase Value Commonwealth of Virginia Department of Human Resource Management State Employee Health Benefits Virginia Chamber of.
Hemoglobin A 1c in Hemodialysis Patients Source: Ix JH. Hemoglobin A1c in hemodialysis patients: Should one size fit all? Clin J Am Soc Nephrol. 2010;5:1539–1541.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
HYPERTENSION The Alabama Department of Public Health’s Hypertension Program.
1 The Case Management Approach October 11, 2012 International Centre, Mississauga, ON Suzanne Lepage Private Health Plan Strategist.
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Commonwealth of Virginia Employee Wellness Department of Human Resource Management State Employee Health Benefits & CommonHealth Virginia Hospital & Healthcare.
* The Asheville Project * An Ounce of Prevention Really IS Worth a Pound of Cure Barry A. Bunting, Pharm.D. Clinical Manager of Pharmacy Services Mission.
New Approaches Focusing on Dynamic Variables Related to Changes in Member’s Health Status: Diabetic HbA1c Predictive Model Brenton B. Fargnoli Blue Cross.
Microvascular and Macrovascular Complications in Hispanic Americans.
PROPRIETARY AND CONFIDENTIAL Internal Strategic Pharmacy Programs Placemat Background 1  Prescriptions are the most frequently used health care benefit,
Click to jump back to the Trivia machine Helpful trivia for the Do-It-Yourself health planner Increase your knowledge and plan a healthy life with healthy.
The Value of Medication Therapy Management Services.
Microsoft’s Wellness & Weight Management Programs December 14, 2005 Tom McPherson Senior Benefits Manager.
Diabetes Free Zone ™ Diabetes Wellness Can Help Prevent a $35,000 Amputation or a $100,000 Heart Attack. That’s Wellness that Makes Financial Sense.
Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice.
An Innovative Approach to Managing Diabetes in a Large Public Health System Donna J. Calvin, PhD, FNP-BC, CNN Post Doctoral Research Associate University.
The Five Steps of MTM The Benefits of MTM MTM empowers individuals by providing them with the education necessary to make informed decisions on the proper.
LDL Program Medical Management Philip E. Johnston, Pharm.D.
Page 1 Overview of Self-Funded Health Plans a step ahead McNeary, Inc.
American Diabetes association(ADA) statistics for 2008.
Evaluating clinical pharmacist impact on diabetes control: outcomes on hemoglobin A1c Mark Amoo PharmD Candidate, Dalton Walsh PharmD Candidate, Kalyani.
Outcomes and Factors Contributing to the Success of a Community Based Patient Self-Management Diabetes Program: The Asheville Project Daniel G. Garrett,
COMMUNITY-BASED CASE MANAGEMENT OF HIGH RISK POPULATIONS DECREASES HEALTHCARE COSTS THE ASHEVILLE EXPERIENCE Barry A. Bunting, Pharm.D. Clinical Manager.
Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia Part 1.
CIA Annual Meeting Session 3203 Measuring Wellness: The Issues? Tom Brogan President June 28 th, 2005.
* Indicates p < 0.05 indicates p < 0.05 Evaluating Clinical Pharmacist Impact on Diabetes Control* Mary Ella Hill, Pharm. D. Candidate; Orijane Dalton,
PowerHour Information 03/09/2011.  Background  Description  Vision  Mission  Measurements  Participation Requirements.
MTM Discussion Topics UPlan Pharmacy Program UPlan decision to add MTM
Lowering Your Cholesterol University Medical Center Community Education Program.
Dr. Raymond J. Fabius, MD President & Chief Medical Officer CHD Meridian Healthcare Beyond Pharmacy Benefit Management: Pharmacy Clinical Leadership™ The.
Peterson-Kaiser Health System Tracker How has diabetes care in the U.S. changed over time?
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Manatee County Utilities Department Manatee County Administrator’s Office Carrots and Sticks : Approach to Controlling Health Care Costs and Creating a.
2016 Medicare Center for Health Care Rights :: January
Consumer Incentives for Health and Health Care: An Employer Perspective Andrew Webber, President and CEO National Business Coalition on Health National.
What is good health? How would you describe good health for yourself? How would you describe good health for those you love? How would you describe a good.
The RAVE Study Renal Athersosclerotic Revascularization Evaluation Reference Tobe SW, Atri M, Perkins N, et al. Renal Athersosclerotic revascularization.
Date of download: 6/21/2016 From: Pharmacist-led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care Ann.
R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.
Pharmacy in Public Health: Describing Populations Course, date, etc. info.
Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia Part 2.
STOPPING DIABETES STARTS NOW
Dr John Cox Diabetes in Primary Care Conference Cork
CMS 5 Star Rating.
Integrating Multiple Specialties into Professional Training and Practice: A Vascular Surgeon’s Perspective John J. Ricotta MD FACS Harold Hawfield Chair.
STOPPING DIABETES STARTS NOW
Diabetes Health Status Report
Amphitheater Public Schools
New Opportunities in Medicare
The Future Use of Technology in Outpatient Care Using the Computerized Patient Record to Implement Principles of Disease Management: Focus on the.
Pharmaceutical care planning 2 Ola Ali Nassr
Value Based Healthcare King’s Health Partners
STOPPING DIABETES STARTS NOW
The Expanding Role of Community Pharmacists in Identification of At-Risk Patients and Provision of Pneumococcal Vaccinations Ed Cohen, PharmD Immunization.
Presentation transcript:

John Miall Risk Manager City of Asheville, NC Asheville Diabetes Disease Management Project John Miall Risk Manager City of Asheville, NC “Miall intro slide”

The Asheville Project “Asheville”

Diabetes-Related Comorbidities 2–4 times greater risk of heart disease 60–65% have hypertension 2–4 times greater risk of stroke 60–70% have some degree of nervous system damage Leading cause of adult blindness Leading cause of ESRD* (40% new cases) >50% lower limb amputations “comorbities” * End-Stage Renal Disease

Diabetes-Related Indirect Costs 8.3 sick-leave days annually 1.7 sick-leave days for employees without diabetes $47 billion in productivity forgone due to disability, absence, and premature mortality “Diabetescosts”

Patient Incentives and Care Model Patient selection / recruitment Patient education — Mission + St. Joseph’s Diabetes Center Matching patients to pharmacists Incentives: PBM* co-pay waivers Labs without co-pays Glucose meters The operative word in pharmaceutical care is “care” (Madge testimonial) “Incentives” *Pharmacy Benefit Manager

How They Do It “How?” “Patient making better food choice. Blood glucose much improved. 2 x 1.5c cm wound RLE. Referred to physician for evaluation and therapy.”

Clinical Outcomes: Avg. Glycosylated Hemoglobin HbA1c “Glycosylated”

City of Asheville Medical Costs Average annual aggregate medical claims “AshCosts” *including prescription drugs for diabetes

City of Asheville Diabetes Sick-Leave Usage Sick leave days “Sick-leave”

Sick Leave Usage By Time In Program Sick leave days “Sick-Program”

QUALITY OF LIFE Baseline At 14 Months into program Source: SF-36 Form “QLife” Baseline At 14 Months into program Source: SF-36 Form

Frequency/Severity Matrix High Frequency Low Severity High Frequency High Severity Frequency Low Frequency Low Severity Low Frequency High Severity “Freq/Severe”